SILVER-ENHANCED IN SITU HYBRIDIZATION AS AN ALTERNATIVE TO FLUORESCENCE IN SITU HYBRIDIZATION FOR ASSAYING HER2 AMPLIFICATION IN CLINICAL BREAST CANCER

被引：0
|
作者：
Han, S. [1 ]
Kim, J. S. [2 ]
Gwak, G. [1 ]
Park, K.
机构：
[1] Inje Univ, Sanggye Paik Hosp, Breast Canc Ctr, Seoul, South Korea
[2] St Mary Hosp Uijungbu, Uijungbu, South Korea
来源：
ANNALS OF ONCOLOGY | 2012年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
50P
引用
收藏
页码：29 / 29
页数：1
相关论文
共 50 条
  • [31] Determination of human epidermal growth factor receptor 2 (HER2) amplification using fluorescence in situ hybridization (FISH), chromogenic in situ hybridization (CISH) and automated silver in situ hybridization (SISH)
    Munawer, Nurhayati H.
    Ali, Siti Aishah Md
    Zain, Reena Md
    Ali, Munirah Mohd
    Muhammad, Rohaizak
    Masir, Noraidah
    Florence, Chandramaya S.
    Mohamed, Rafie K.
    Arbi, Asmiati
    Akmal, Sharifah Noor
    Das, Srijit
    AFRICAN JOURNAL OF BIOTECHNOLOGY, 2011, 10 (73): : 16429 - 16436
  • [32] Assessment of HER2 Gene Status in Breast Cancer by Dual-color Silver-enhanced in situ Hybridization and its Concordance with FISH Test
    Zhu, Yifei
    Li, Ming
    Lv, Hong
    Bai, Qianming
    Zhou, Xiaoyan
    Yang, Wentao
    LABORATORY INVESTIGATION, 2025, 105 (03)
  • [33] Comparison of Dako fluorescence in situ hybridization assays (FISH and IQFISH) in the assessment of HER2 amplification in breast cancer
    McClanaghan, Maegan
    Vandenberg, Jill
    Colley, Elizabeth
    Stead, Ronald
    JOURNAL OF HISTOTECHNOLOGY, 2014, 37 (03) : 90 - 94
  • [34] Quantitative Imaging Analysis Fluorescence In Situ Hybridization Validation for Clinical HER2 Testing in Breast Cancer
    Wilcock, Diane M.
    Moore, Kristina H.
    Rowe, Leslie
    Mahlow, Jonathan
    Jedrzkiewicz, Jolanta
    Cleary, Allison S.
    Lomo, Lesley
    Ruano, Ana L.
    Gering, Maarika
    Bradshaw, Derek
    Maughan, Meghan
    Tran, Phuong
    Burlingame, Jesse
    Davis, Richard
    Affolter, Kajsa
    Albertson, Daniel J.
    Adelhardt, Parisa
    Kim, Jong Take
    Coleman, Joshua F.
    Deftereos, Georgios
    Gulbahce, Evin H.
    Sirohi, Deepika
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2023, 147 (12) : 1402 - 1412
  • [35] Rapid Fluorescence in Situ Hybridization (FISH) for HER2 Assessment in Breast and Gastroesophageal Cancer
    Dokus, B. J.
    Allen, S. F.
    Steinmetz, H. B.
    Marotti, J. D.
    Tsongalis, G. J.
    Tafe, L. J.
    JOURNAL OF MOLECULAR DIAGNOSTICS, 2013, 15 (06): : 908 - 908
  • [36] A fluorescence in situ hybridization (FISH) microfluidic platform for detection of HER2 amplification in cancer cells
    Kao, Kai-Jie
    Tai, Chien-Hsuan
    Chang, Wen-Hsin
    Yeh, Ta-Sen
    Chen, Tse-Ching
    Lee, Gwo-Bin
    BIOSENSORS & BIOELECTRONICS, 2015, 69 : 272 - 279
  • [37] Comparison of dual-colour chromogenic in-situ hybridization and fluorescence in-situ hybridization in the assessment of HER2 gene amplification in breast carcinoma
    Conlon, Susan
    Colgan, Aoife
    Allen, David
    O'Grady, Anthony
    Kay, Elaine W.
    HISTOPATHOLOGY, 2011, 58 (02) : 320 - 321
  • [38] Double staining chromogenic in situ hybridization is a useful alternative to fluorescent in situ hybridization: first comparative study of HER2 and TOP2A gene amplification in breast cancer
    Lacroix-Triki, M.
    Mounie, E.
    Charafe-Jauffret, E.
    Jacquemier, J.
    BREAST CANCER RESEARCH AND TREATMENT, 2007, 106 : S85 - S86
  • [39] Delay to Formalin Fixation Effect on HER2 Test in Breast Cancer by Dual-Color Silver-enhanced In Situ Hybridization (Dual-ISH)
    Khoury, Thaer
    Liu, Qian
    Liu, Song
    APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY, 2014, 22 (09) : 688 - 695
  • [40] Assessing HER2 amplification in breast cancer: findings from the Australian In Situ Hybridization Program
    Michael Bilous
    Adrienne L. Morey
    Jane E. Armes
    Richard Bell
    Peter H. Button
    Margaret C. Cummings
    Stephen B. Fox
    Glenn D. Francis
    Brigid Waite
    Glenda McCue
    Wendy A. Raymond
    Peter D. Robbins
    Gelareh Farshid
    Breast Cancer Research and Treatment, 2012, 134 : 617 - 624
12345